报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 12.49% | 8.42% | 88.1% | 13/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 6.64% | -2.21% | 98.8% | 19/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 3.34% | -4.84% | -72.6% | 18/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 12.19% | -7.23% | 5.82% | 23/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 11.52% | -8.43% | 69.66% | 15/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 6.79% | -8.24% | 93.45% | 26/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 3.51% | -0.28% | -73.29% | 32/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 13.14% | -22.48% | 4.45% | 49/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 12.58% | -27.24% | 70% | 41/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 7.4% | -38.49% | 110.23% | 48/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 3.52% | -18.14% | -79.23% | 43/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 16.95% | -18.23% | -1.97% | 52/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 17.29% | 2% | 43.72% | 34/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 12.03% | 4.61% | 179.77% | 38/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 4.3% | 2% | -79.26% | 37/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 20.73% | -30.88% | 80.26% | 46/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-06-30 | 11.5% | 2% | -61.65% | 39/129 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
2019-12-31 | 29.99% | 44.25% | 44.25% | 15/129 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
2018-12-31 | 20.79% | 63.32% | 63.32% | 28/129 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
2017-12-31 | 12.73% | 2% | 2% | 53/129 | 13.82% | 健尔康 | 84.09% | 行业排名> |